ADVERTISEMENT

Daniel DeAngelo, MD, PhD

Daniel DeAngelo, MD, PhD

Videos

Promising Outcomes of FGFR1 Inhibitor Pemigatinib for Myeloid Lymphoid Neoplasms

08/28/2023

Daniel DeAngelo , MD, PhD;

Daniel DeAngelo, MD, PhD, presents data on the promising outcomes of pemigatinib, an FGFR1 inhibitor, among patients with myeloid lymphoid neoplasms, at the 2023 Great Debates & Updates in Hematologic Malignancies meeting.

Daniel DeAngelo, MD, PhD, presents data on the promising outcomes of pemigatinib, an FGFR1 inhibitor, among patients with myeloid lymphoid neoplasms, at the 2023 Great Debates & Updates in Hematologic Malignancies meeting.

Daniel DeAngelo, MD, PhD,...

08/28/2023

Oncology

Daniel DeAngelo, MD, PhD

Videos

Diagnosing and Treating Patients With Indolent and Advanced Systemic Mastocytosis

08/19/2023

Daniel DeAngelo , MD, PhD;

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Daniel DeAngelo, MD, PhD, shares insights into recent treatment developments and diagnostic criteria for patients with indolent and systemic mastocytosis.

At the 2023 Great Debates & Updates in Hematologic Malignancies meeting, Daniel DeAngelo, MD, PhD, shares insights into recent treatment developments and diagnostic criteria for patients with indolent and systemic mastocytosis.

At the 2023 Great Debates &...

08/19/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement